Arvinas Inc (ARVN)
35.23
0.00 (0.00%)
USD |
NASDAQ |
May 24, 16:00
35.23
0.00 (0.00%)
After-Hours: 20:00
Arvinas Revenue (TTM): 71.30M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 71.30M |
| December 31, 2023 | 78.50M |
| September 30, 2023 | 159.40M |
| June 30, 2023 | 158.00M |
| March 31, 2023 | 137.30M |
| December 31, 2022 | 131.30M |
| September 30, 2022 | 126.70M |
| June 30, 2022 | 102.80M |
| March 31, 2022 | 74.50M |
| December 31, 2021 | 53.50M |
| September 30, 2021 | 26.62M |
| June 30, 2021 | 24.91M |
| Date | Value |
|---|---|
| March 31, 2021 | 25.16M |
| December 31, 2020 | 25.90M |
| September 30, 2020 | 24.50M |
| June 30, 2020 | 46.95M |
| March 31, 2020 | 45.22M |
| December 31, 2019 | 43.00M |
| September 30, 2019 | 41.52M |
| June 30, 2019 | 14.85M |
| March 31, 2019 | 14.23M |
| December 31, 2018 | 14.32M |
| September 30, 2018 | 13.46M |
| June 30, 2018 | 11.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.85M
Minimum
Jun 2019
159.40M
Maximum
Sep 2023
70.60M
Average
50.23M
Median
Revenue (TTM) Benchmarks
| Pfizer Inc | 55.09B |
| Johnson & Johnson | 89.66B |
| Bristol-Myers Squibb Co | 45.53B |
| Janux Therapeutics Inc | 7.287M |
| ACADIA Pharmaceuticals Inc | 813.81M |